* price as on 12 Sep 2025
Financial
Mar-25A Mar-26F Mar-27F Mar-28F
Revenue (Rsm) 28,470 30,605 33,479 36,704
Operating EBITDA (Rsm) 4,996 5,054 5,590 6,192
Net Profit (Rsm) 3,704 3,782 4,106 4,600
Core EPS (Rs) 10.2 10.3 11.2 12.5
Core EPS Growth 1.4% 0.9% 8.6% 12.0%
FD Core P/E (x) 32.24 31.58 29.08 25.96
DPS (Rs) 3.0 3.3 3.3 3.3
Dividend Yield 1.08% 1.01% 1.01% 1.01%
EV/EBITDA (x) 23.62 23.40 20.80 18.42
P/FCFE (x) 125.63 146.94 37.27 34.33
Net Gearing (6.9%) (4.9%) (12.0%) (18.4%)
P/BV (x) 5.83 5.18 4.60 4.07
ROE 19.4% 17.4% 16.7% 16.6%
% Change In Core EPS Estimates
InCred Research/Consensus EPS (x)
(Rs mn) Mar-25A Mar-26F Mar-27F Mar-28F
Total Net Revenues 28,470 30,605 33,479 36,704
Gross Profit 14,275 15,223 16,686 18,330
Operating EBITDA 4,996 5,054 5,590 6,192
Depreciation And Amortisation (561) (645) (757) (757)
Operating EBIT 4,435 4,409 4,833 5,435
Financial Income/(Expense) (59) (65) (80) (85)
Pretax Income/(Loss) from Assoc.
Non-Operating Income/(Expense) 556 633 685 743
Profit Before Tax (pre-EI) 4,931 4,977 5,438 6,092
Exceptional Items
Pre-tax Profit 4,931 4,977 5,438 6,092
Taxation (1,184) (1,195) (1,332) (1,493)
Exceptional Income - post-tax (43)
Profit After Tax 3,704 3,782 4,106 4,600
Minority Interests 1
Preferred Dividends
FX Gain/(Loss) - post tax
Other Adjustments - post-tax
Net Profit 3,704 3,782 4,106 4,600
Recurring Net Profit 3,747 3,782 4,106 4,600
Fully Diluted Recurring Net Profit 3,747 3,782 4,106 4,600
(Rs mn) Mar-25A Mar-26F Mar-27F Mar-28F
EBITDA 4,996 5,054 5,590 6,192
Cash Flow from Invt. & Assoc. 1
Change In Working Capital (2,546) (3,414) (1,409) (1,578)
(Incr)/Decr in Total Provisions
Other Non-Cash (Income)/Expense
Other Operating Cashflow 556 633 685 743
Net Interest (Paid)/Received (59) (65) (80) (85)
Tax Paid (1,184) (1,195) (1,332) (1,493)
Cashflow From Operations 1,763 1,013 3,454 3,778
Capex (813) (200) (250) (300)
Disposals Of FAs/subsidiaries
Acq. Of Subsidiaries/investments
Other Investing Cashflow
Cash Flow From Investing (813) (200) (250) (300)
Debt Raised/(repaid)
Proceeds From Issue Of Shares
Shares Repurchased
Dividends Paid (1,102) (1,102) (1,212) (1,212)
Preferred Dividends
Other Financing Cashflow 98 0 0
Cash Flow From Financing (1,004) (1,102) (1,212) (1,212)
Total Cash Generated (53) (289) 1,992 2,266
Free Cashflow To Equity 951 813 3,204 3,478
Free Cashflow To Firm 1,010 878 3,284 3,563
(Rs mn) Mar-25A Mar-26F Mar-27F Mar-28F
Total Cash And Equivalents 1,424 1,135 3,127 5,393
Total Debtors 2,744 4,025 4,586 5,028
Inventories 3,281 4,863 5,503 6,536
Total Other Current Assets 7,336 7,336 7,336 7,336
Total Current Assets 14,784 17,358 20,552 24,293
Fixed Assets 3,712 3,267 2,760 2,303
Total Investments
Intangible Assets 7,926 7,926 7,926 7,926
Total Other Non-Current Assets 486 486 486 486
Total Non-current Assets 12,124 11,679 11,172 10,715
Short-term Debt
Current Portion of Long-Term Debt
Total Creditors 2,903 2,240 1,910 1,672
Other Current Liabilities 2,294 2,294 2,294 2,294
Total Current Liabilities 5,197 4,534 4,204 3,966
Total Long-term Debt
Hybrid Debt - Debt Component
Total Other Non-Current Liabilities
Total Non-current Liabilities
Total Provisions 1,216 1,328 1,451 1,585
Total Liabilities 6,413 5,862 5,655 5,551
Shareholders Equity 20,495 23,065 25,959 29,347
Minority Interests
Total Equity 20,495 23,065 25,959 29,347
Mar-25A Mar-26F Mar-27F Mar-28F
Revenue Growth 3.3% 7.5% 9.4% 9.6%
Operating EBITDA Growth 4.1% 1.2% 10.6% 10.8%
Operating EBITDA Margin 17.5% 16.5% 16.7% 16.9%
Net Cash Per Share (Rs) 3.88 3.09 8.52 14.69
BVPS (Rs) 55.81 62.81 70.69 79.92
Gross Interest Cover 74.78 67.83 60.41 63.94
Effective Tax Rate 24.0% 24.0% 24.5% 24.5%
Net Dividend Payout Ratio 34.3% 32.0% 29.5% 26.3%
Accounts Receivables Days 30.50 40.37 46.94 47.80
Inventory Days 78.62 96.62 112.66 119.58
Accounts Payables Days 72.82 61.02 45.10 35.58
ROIC (%) 21.9% 18.9% 19.8% 21.2%
ROCE (%) 23.0% 20.2% 19.7% 19.7%
Return On Average Assets 15.0% 13.8% 13.8% 14.0%

Analyst(s)

Rohan KALLE

(91) 22 4161 1561 rohan.kalle@incredresearch.com

Nishant BAGRECHA

(91) 22 4161 1564 nishant.bagrecha@incredresearch.com